Fig. 1. An agexzinc interaction affecting hemoglobin concentrations. As initial age of entry to the study increased, zinc-treated children maintained hemoglobin levels. In contrast, the children who did not receive zinc exhibited a significant decline (8% predicted decrease) from 28 to 66 months, p<0.01.